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 1 
Abstract 2 
Purpose 3 
Age-related macular degeneration (AMD) is the leading cause of visual impairment in older adults in the UK. 4 
This study sought to characterise AMD patients who seek the services of the Macular Society, and determine 5 
the level and source of their dietary knowledge. 6 
Methods 7 
A questionnaire was designed, validated and administered to 158 participants. The questions covered 8 
demographic data and knowledge of nutrition and supplementation. 9 
Results 10 
The mean age of participants was 79 years, 61% of which were female and 27% were registered visually 11 
impaired. Only 55% of the participants thought diet was important for eye health, 63% felt that they had not 12 
received enough information about AMD. The participants reported that their information mainly came from 13 
non-professional support groups. Most participants identified healthy food, but could not say why, and were 14 
not able to identify carotenoid rich foods. 15 
Conclusions  16 
The results will inform design of education and dissemination methods regarding dietary information. 17 
 18 
Keywords: age-related macular degeneration, diet, lifestyle factors, nutrition, survey.  19 
 20 
 21 
 22 
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 23 
Introduction 24 
Age-related macular degeneration (AMD) is the leading cause of visual impairment in older adults (> 50 years) 25 
in the UK (RNIB, 2010). Currently, there are several AMD classification schemes which have been developed to 26 
try to standardise research and clinical practice. Ferris et al. (2013), proposed a five stage classification scale 27 
which has achieved some consensus among AMD specialists: Stage 1) No apparent aging changes, 2) Normal 28 
aging changes, known as ‘drupelets’ (small drusen ≤63 µm) 3) Early AMD – medium sized drusen ≤125µm 4) 29 
Intermediate AMD - large drusen and pigmentary (hyper or hypo) anomalies and 5) Late AMD – geographic 30 
atrophy and/or neovascularisation (Ferris et al., 2013). AMD can cause a gradual loss of central visual function 31 
occurring within months, or over many years, and late AMD can cause central visual loss and metamorphopsia 32 
within days or even hours. Many AMD patients have been given a simplified classification using the terms ‘dry’ 33 
to describe geographic atrophy and ‘wet’ to describe neovascularisation or exudation.  Visual loss is strongly 34 
associated with a reduction in quality of life as it will limit the ability to perform daily activities. Subsequently, 35 
depression often occurs in these patients (Mathew et al., 2011). It has been predicted that the prevalence of 36 
AMD will increase significantly by 2020 due to the generalised aging of the population (Owen et al., 2012; 37 
Shaw, 2006), but also due to socio-economic factors such as poor nutrition and increased smoking in some 38 
areas (Huffman et al., 2012; Wennergren et al., 2013). Therefore it can be expected that there will be a 39 
growing need for support services for people with this condition. 40 
Diagnosis for AMD in the UK occurs via an ophthalmologist (RNIB, 2010). Often, after the initial diagnosis, the 41 
patient will receive written material regarding the disease from the ophthalmology department. The decision 42 
then rests with the ophthalmologist as to whether the patient requires any treatment. This might take the 43 
form of anti-vascular endothelial growth factor medications (e.g. Lucentis®) or surgery/laser work to wet AMD 44 
conditions, low vision services or placement upon a sight impairment register. If the AMD is of an early or 45 
intermediate stage, the patient will have very little contact with any hospital services for some years – if at all – 46 
unless the AMD changes to a late stage. Patients are advised to have a yearly eye examination with an 47 
optometrist who will monitor the condition, but is often unable to provide physical or psychological help 48 
without referral (AOP, 2001). 49 
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Whilst specialists agree that smoking has a big impact on AMD and that cessation will halt progression of the 50 
disease (Caban-Martinez et al., 2011), there are conflicting research findings and therefore conflicting 51 
information provided by eye care practitioners regarding the impact of nutrition on AMD (Kent, 2007). 52 
The Age-Related Eye Disease Study (AREDS) reported that nutritional supplementation in people with 53 
intermediate AMD can reduce their risk of progression to advanced AMD by 25 % (Kassoff et al., 2001). While 54 
the AREDS was in progress, evidence emerged to suggest that the dietary nutrients lutein and zeaxanthin may 55 
be more effective than other nutrients in reducing AMD risk or progression due to their antioxidant and photo 56 
protective properties (Beatty, Koh, Phil, Henson, & Boulton, 2000). The plausibility for this hypothesis is due to 57 
the high concentration of lutein, zeaxanthin, and a related compound meso-zeaxanthin, in the macula, 58 
particularly in the fovea, which form the macular pigment (Khachik, Bernstein, & Garland, 1997). The 59 
protective properties of the macular pigment are now well established and include the ability to interact with 60 
free radicals, prevent lipid peroxidation and filter out incoming, high energy blue light (Alves-Rodrigues & 61 
Shao, 2004; Ham, 1983; Junghans, Sies, & Stahl, 2001; RNIB, 2010) . Some studies also show a link between 62 
increased intake of lutein and zeaxanthin, and higher macular pigment levels (Bhosale, Zhao, & Bernstein, 63 
2007; Vishwanathan, Goodrow-Kotyla, Wooten, Wilson, & Nicolosi, 2009; Wenzel, Sheehan, Burke, Lefsrud, & 64 
Curran-Celentano, 2007). Supplementation studies report increases in macular pigment of between 21 and 65 
57% following lutein and zeaxanthin supplementation in people with healthy eyes. Increases in macular 66 
pigment of between 24% and 36% have been reported in people with retinal disease. One randomized 67 
controlled trial reported an improvement in several measures of visual function in a group of veterans who 68 
supplemented with 10 mg of lutein for one year (Richer et al., 2004; Ziemssen, Warga, Bartz-Schmidt, & 69 
Wilhelm, 2005). A recent study by Loughman et al. (2012) suggests that supplementation with all three 70 
macular carotenoids may offer advantages both in terms of macular pigment optical density (MPOD) response 71 
and visual performance enhancement (Loughman et al., 2012).  The AREDS team recently released the results 72 
for their follow-up study (AREDS 2) which encompassed lutein and zeaxanthin to the original AREDS 73 
supplement formulation (Chew et al., 2013). The study found that adding lutein and zeaxanthin did not further 74 
reduce the risk of progression to advanced AMD. However, investigators report that lutein and zeaxanthin may 75 
be useful substitutes for beta-carotene in the original formulation (Cangemi, 2007). Despite the conflicts, 76 
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overall, the research evidence suggests that high macular pigment levels could reduce risk for onset or 77 
progression of AMD. 78 
Because xanthophylls are not synthesised by the human body, they have to be acquired either in the diet or by 79 
supplementation. Research shows that the highest mole percentage of lutein and zeaxanthin are in egg yolk, 80 
maize (corn), spinach, collard greens (like cabbage) and kale (Hosseini, Mosallaei, & Kalameh, 2009; 81 
Sommerburg, Keunen, Bird, & van Kuijk, 1998). Maize has been identified as the vegetable with the highest 82 
quantity of lutein and orange pepper was the vegetable with the highest amount of zeaxanthin. Amounts of 83 
lutein and zeaxanthin are also reported to be present in kiwi fruit, grapes, orange juice, courgettes, and 84 
different kinds of squash. Predominantly, leafy green vegetables have a highest content of lutein and 85 
zeaxanthin. 86 
Despite the body of evidence in support of a role for dietary modification or nutritional supplementation in 87 
reducing risk of progression of AMD, neither patients nor practitioners are clear about what kind of 88 
supplements to take, or how foods should be prepared and consumed in order to maximise absorption of 89 
useful nutrients (Kent, 2007). To add to the confusion, there are many nutritional supplements aimed at those 90 
with AMD currently on the market, with varying degrees of dosage and some without any research basis at all 91 
(Arora, Musadiq, Mukherji, & Yang, 2004; Loughman, Nolan, Stack, & Beatty, 2011). Many do not contain the 92 
AREDS formulation. Research has shown that given more choices, patients are much more likely to be 93 
overwhelmed (Kent, 2007). Supplements are not regulated in the same manner as medication in the UK (EU 94 
Directive, 2002) and it is very difficult to identify which supplements are likely to be of any benefit.  95 
Since many local authorities do not have standardised rehabilitation services in place (Gillespie-Gallery, 96 
Conway, & Subramanian, 2012), some patients have been turning to non-professional charities, such as The 97 
Macular Society, to acquire information and support. The Macular Society is the only national UK charity that is 98 
dedicated solely to helping those with diseases of the macula. They provide impartial information and practical 99 
support for visually impaired people, their families and carers. They also “provide information for health 100 
professionals, campaign for better services, sponsor research and raise awareness of macular degeneration 101 
and preventative measures” (The Macular Society, 2013, http://www.macularsociety.org/how-we-help).  102 
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The objectives of this study were firstly to find out who pursues the help of a non-professional charity, and 103 
secondly, to determine the beliefs and understanding that these AMD patients have about the impact of 104 
nutrition on the condition, and where patients have obtained information about nutrition. 105 
Methods 106 
Participants 107 
A total of 158 participants were recruited between January 2012 and March 2012. Recruitment was via the 108 
Macular Society helpline volunteer worker. Patients aged over 55 years of age who contacted the Macular 109 
Society helpline between January 2012 and March 2012 were asked if they would like to take part in a 110 
telephone survey (once they had received all the assistance they needed from the Macular Society). Pre-111 
requisites for potential participants were that they should be aged over 55 years and have been diagnosed 112 
with a form of AMD; exclusion criteria were the inability to hear and reply to questions in English over the 113 
telephone.  No attempt was made to define and categorise the amount of visual loss the participant had, as 114 
the objective was to assess typical patients seeking the Macular Society services.  115 
Ethics 116 
The procedures followed were in accordance with the ethical standards of the Aston University Ethics 117 
Committee on human experimentation that conform to the Declaration of Helsinki 1975, revised Hong Kong 118 
1989. 119 
 120 
Survey Design 121 
A systematic literature review of research on AMD patient’s perceptions of nutrition and AMD was conducted 122 
of the following databases: Web of Knowledge, The Cochrane Library, Optics Infobase, Ovid Journals, 123 
PsycArticles, NCBI databases and Wiley Online Library. The following key-terms were used: “Age-related 124 
macular degeneration”, “Nutrition”, “Survey”, “Attitudes”, “Behaviours” and “Diet”. This review did not 125 
identify any existing measure of patient’s perceptions of nutrition, but found most surveys looked at 126 
nutritional behaviours (Montgomery et al., 2010). As a result, a 36 question cross sectional survey was 127 
designed to explore nutritional habits, supplement usage, physical abilities in food preparation and cooking, 128 
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and sources of knowledge in order to ascertain the beliefs AMD patients have, and compare their beliefs with 129 
their behaviours. Not all the results of the 36 questions are covered in this paper. Because the survey was 130 
exploratory, it was designed mainly with open ended questions in order to ensure responses reflected 131 
participants’ true beliefs. In addition, some closed ended questions were included with response scales to 132 
grade participants’ feelings.  133 
The survey was then piloted on eight AMD participants, from the Macular Society, to test the reliability, 134 
comprehensibility, and understanding among an informed population. This ‘face validity’ (i.e., does the 135 
questionnaire appear correct at face value) was the only means of validation that it was possible to perform, 136 
due to a lack of other instruments to compare the results with. Initially, the eight patients completed the 137 
survey via a telephone interview.  Three weeks later, the patients attended a focus group that had two parts: 138 
firstly, the participants completed the survey once more. Next, the participants had a recorded, guided 139 
informal discussion structured by a moderator – the volunteers were asked to comment on how easy the 140 
questions were to understand and opinions on the topics covered. The results of this meeting were analysed 141 
to further refine the survey, which was altered accordingly (e.g. the terms ‘wet’ and ‘dry were employed to 142 
coincide with many patient’s understanding of AMD classification, extra options were added to some 143 
questions, some questions were removed or re-worded and additional instructions were added). The final 144 
survey (see Appendix 1.) was then administered to the cohort. 145 
The initial questions covered demographic topics such as gender, age, employment, social history, type and 146 
length of time with AMD and visual impairment registration. Opinions on diet and supplementation were 147 
obtained, with particular interest in whether participants could identify lutein and zeaxanthin rich foods (e.g. 148 
kale) amongst other vegetables. Participants were also asked where they had acquired any information about 149 
the condition from (for instance, an ophthalmologist, optician, Macular Society etc). The questions 150 
subsequently focused on perceived state of vision and health, and ability to perform preparation and cooking 151 
of food. Participants also provided a food diary for 24 hours, as studies have shown there is less measurement 152 
error in food recording than in food frequency questionnaires, and the ability to study associations between 153 
diet and chronic diseases is slightly easier with food diaries (Bartlett & Eperjesi, 2004; Block, Hartman, & 154 
Dresser, 1986). The results of the questions relating to cooking abilities, perceived health and vision states and 155 
the food diary is beyond the scope of this paper and will be discussed in a future paper. 156 
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Procedure 157 
If a patient agreed to take part, their name and contact details were taken by the helpline worker.  The 158 
potential participants were read an information factsheet informing them what the survey would involve, how 159 
long it would take and how the information would be stored. If the patient decided to participate, an oral 160 
informed consent was obtained over the telephone and they were advised that they could withdraw at any 161 
time. Usually an appointment was scheduled for a future telephone interview or the interview began 162 
immediately if the patient wished.  163 
 164 
They were then contacted at a convenient time by one of four Macular Society employees who would 165 
administer the telephone interview and fill in the survey online at the same time (Bristol Online Surveys). The 166 
telephone interview lasted approximately 25 minutes, and was not recorded. Each volunteer was trained (by 167 
RS) to ask the questions only, without bias, and if the participant had any questions regarding the survey, they 168 
were given the author’s contact details, although no participant made any contact. 169 
 170 
 171 
Data Analysis 172 
The results were analysed to find the mean, median and standard deviation using the software Microsoft 173 
Excel. Data from Excel was then used to create charts, and used in statistical software IBM SPSS (version 20) to 174 
draw comparisons between supplement cost and usage using chi-square statistics. Qualitative data was 175 
grouped into categories and general themes were extracted to then use in SPSS. 176 
 177 
Results 178 
Sample Characteristics 179 
Table 1 shows the demographic characteristics of the sample. The gender distribution of the 158 participants 180 
showed that there were significantly more females (61%) in the sample than males (39%) (chi-square p= 0.05). 181 
The participants ranged in age from 56 to 95 years; the median age was 80 years. There was a nearly even split 182 
between ‘wet’ (47%) and ‘dry’ types of AMD (49%), with a small percentage of participants who were unsure 183 
of their AMD classification. The median duration of having the condition was 5 years, ranging from 1 to 25 184 
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years. The majority of participants lived in their own home – either rented, mortgaged or owned outright, and 185 
participants mainly either lived with their partner or alone. The majority of participants were not registered 186 
partially sighted or blind, although there was a trend for those participants that had the condition for longer to 187 
be on a register ( Kruskal Wallis H p= 0.09). 188 
Characteristic                                                                         Percentage of Participants 
Living Arrangements         Own home                                                   88% 
                                              With family/friends                                    3% 
                                              Sheltered accommodation                        7% 
                                              Other                                                             2% 
With                                     Partner                                                          50% 
                                              Alone                                                             47% 
                                              Other family members                                4% 
Registration                        Blind                                                               16% 
                                              Partially sighted                                           21% 
                                              None                                                              63% 
Supplement price               No cost                                                          17% 
   willing to pay                   £1-5                                                                10% 
                                              £6-10                                                              21% 
                                              £11-15                                                            24% 
                                              £16-20                                                           12% 
                                              £20+                                                               17% 
 189 
                                                            Table 1. Demographic characteristics of participants.                                                                     190 
Patient’s perceptions of diet and eye health 191 
When asked their overall opinions on diet and health, 87% of participants believe that diet affects general 192 
health, and 68% believe that diet affects eye health.  193 
Figure 1 shows the beliefs that participants held about specific foods:- leafy green vegetables, which are good 194 
sources of lutein and zeaxanthin, other fruit and vegetables, and dairy products . Participants were asked if 195 
they believed each food was beneficial for eye health, and if they answered ‘Yes’, they were asked why they 196 
thought so. 197 
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                198 
Figure 1. Participant’s beliefs about the eye health benefits of several foods. ‘Yes’ indicates the participant believed the 199 
food was beneficial, ‘No’ indicates the participant did not believe that the food was beneficial, and ‘DK’ indicates the 200 
participant didn’t know. 201 
As shown, the majority of participants were accurate in their perceptions of the food which would be 202 
beneficial for eye health. Leafy green vegetables such as spinach, cabbage and kale were identified as being 203 
beneficial by over 80% of participants. Ice-cream was identified as not beneficial for eye health by 72% of 204 
participants. For mango, bilberries and peppers, 25% or more participants answered ‘don’t know’, and 205 
responses were more mixed. Males responded with ‘Don’t know’ on average 10% more than females. 206 
When asked why they felt a particular food was valuable for eye health, the majority of participants (81%) 207 
struggled to verbalise why they held that belief. Of those that did express the reasoning behind their beliefs, 208 
the majority of the responses had nothing to do with nutrients. Only 2% of those that felt spinach and kale are 209 
beneficial for eye health knew that they contain lutein. Some participants responded that leafy green 210 
vegetables were known to be good for eyes (spinach 5%, kale 3%, and cabbage, 6%), while others merely 211 
responded that coloured foods were good for eyes (carrots 2%, peppers 5%, and mango 1%). Some 212 
participants (1%) responded that spinach and kale contained iron, which was why they felt it would be 213 
beneficial for eye health. One percent of participants felt that carrots were beneficial because they contained 214 
carotene, and that peppers were beneficial because they contained vitamin C. Participants also included the 215 
following reasons for carrots: “They help you see in the dark” (6%), “war propaganda” (6%), “We were told to 216 
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eat them by parents” (6%). One percent of participants responded that their optician had told them that 217 
mango was good for eye health. Participants also responded that they had “read it was beneficial somewhere” 218 
for some foods (peppers 1%, bilberries 5%). 219 
As mentioned earlier, no participant felt that ice-cream was beneficial for eye health. Of the participants that 220 
felt that cheese was beneficial for eye health (18%), none could give a reason why.  221 
Nutritional supplementation 222 
The participants were asked who they had discussed nutritional supplementation with - 30% of the 223 
participants had discussed it with their ophthalmologist, 15% with their optometrist and 8% had consulted 224 
their GP. 225 
Participants were asked if they currently took a nutritional supplement(s). Of those that responded ‘yes’ (79%; 226 
of males and 79% of females), the majority (60%) took the supplement once per day. The most popular brand 227 
of ocular supplement used was I-caps [Alcon] (24%), followed by PreserVision [Bausch&Lomb] (19%), Ocuvite 228 
[Bausch&Lomb] (14%), Viteyes [Viteyes] (14%), Macushield [Macuvision] (11%), Retinex [Healthspan] (8%), 229 
Visionace [Vitabiotics] (5%), and Vitalux [Novartis] (3%). Some patients took more than one brand with a 230 
variety of dosing methods. 231 
                                       232 
                                              Figure 2. Reasons for not taking Nutritional Supplements. 233 
Those that responded that they did not take a nutritional supplement (33 participants - 21% male and 21% 234 
female) were asked to describe these reasons as shown in Figure 2. The majority felt that they were not sure 235 
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of the effectiveness of supplementation, but many listed an ‘other’ reason for not taking supplements (but did 236 
not provide an explanation for what that reason might be). 237 
 238 
The participants were asked how much money would they be willing to spend on a supplement (per month or 239 
30 day’s supply) if they had proof of its worth. The results are shown in Table 1. The supplement usage data 240 
were cross-tabulated with the amount of money participants were willing to spend on a monthly supplement, 241 
using chi-square statistics. The results show a significant association between those that do take supplements 242 
being willing to spend more money on supplements, and those that do not take supplements are willing to 243 
spend less money on supplementation (p≤0.000). Of the participants that did not take supplements, 67% were 244 
not willing to spend any money on supplementation even if they had proof of its worth. 245 
 246 
Patient information 247 
Figure 3 displays the opinions that the participants held about AMD and living with the condition. Over half the 248 
participants (51%) believed that AMD patients do not receive enough information about nutrition and lifestyle 249 
choices; an additional 12% strongly believed this. The participants were asked where they had received 250 
information on AMD from – (they were allowed to pick more than one option): 40% of participants had 251 
received information from their ophthalmologist. As expected, 92% had received information from 252 
organisations such as The Macular Society.  Just over half of the cohort believed that AMD could be prevented 253 
by lifestyle choices such as nutrition. 254 
                               255 
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                                                                                                   Figure 2. Knowledge of AMD 256 
 257 
Discussion  258 
The demographic data has shown three interesting findings: 259 
Firstly, research has shown that females (especially in this age-group) are more likely to ask for and utilise 260 
health care services (Cameron, Jing, Manheim, & Dunlop, 2010; Vaidya, Partha, & Karmakar, 2012), so it could 261 
be speculated that more females than males seek out the services of the Macular Society. 262 
Secondly, only 37% of the participants were registered on a visual impairment register, despite 47% of 263 
participants having ‘wet’ AMD (although this was self-reporting and the severity was not assessed). The Royal 264 
National Institute of the Blind (RNIB)’s survey into certification and registration in 2011 (Boyce, 2012), shows a 265 
steady decline in the number of registrations per year despite the fact that the prevalence of visual 266 
impairment is increasing (Owen et al., 2012; RNIB, 2010). They attribute this decrease in registration not to a 267 
lack of interest in registration by the patient, but rather to the length of time it takes to complete the 268 
Certificate of Visual Impairment (CVI) by the professionals involved.   269 
Finally, nearly half the participants lived alone – this can have a huge impact on their quality of life. One study 270 
(Vale, 2004) has shown that 63% of all blind and partially sighted people live alone – a higher figure than the 271 
‘normal’ sighted elderly population. It would have been useful to find out if participants had a mobility issue, 272 
as this may have affected why the participants had chosen to seek the Macular Society’s services – a helpline is 273 
easier to access than physically going to see an Ophthalmologist or Optometrist for advice, and this could 274 
explain why patients did not report sourcing their information from an ophthalmologist or optometrist. 275 
 276 
The cohort was a group of highly motivated individuals who had taken the initiative to contact the Macular 277 
Society but still felt that they needed more advice, particularly relating to nutrition. Although some of the 278 
participants needed to rely on others for support and felt they had considerable visual impairment, the desire 279 
to remain independent and improve their vision is evidenced through seeking the services of the Macular 280 
Society, and using other healthcare professionals such as dieticians and specialist doctors. 281 
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This sample may not represent all patients seeking services from organisations like the Macular Society. Access 282 
to other organisations would provide a more rounded view. It would be important to find out the opinions of 283 
those with AMD who have not sought support from non-professional organisations, and this will form the next 284 
step to the overall project.   285 
Patient’s perceptions 286 
This study provides a clear picture of the perceptions of diet and eye health among a sample of AMD patients. 287 
The majority of participants agreed that specific foods can affect general health, and participants also agreed 288 
that specific foods affect eye health. The results of the specific food questions show that the majority of 289 
participants felt that the vegetables and fruit were beneficial for eye health, and these perceptions were 290 
generally accurate. However, apart from a few individuals who mentioned specific nutrients in regard to 291 
specific foods (e.g., lutein in kale), most participants were not able to identify why these foods helped promote 292 
eye health, or gave vague responses such as “I read it somewhere”. This suggests that participants, who would 293 
be expected to be well-informed, were not clear about the links between diet and eye health.  294 
Information 295 
The majority of participants reported that they did not have enough information on nutrition and its 296 
relationship to AMD. As expected, all participants reported that they had received information from 297 
organisations such as the Macular Society. In contrast, not all the participants reported getting information 298 
from their ophthalmologist, which is consistent with previous studies (Dahlin-Ivanoff, Sjöstrand, & Klepp, 1998; 299 
RNIB, 2013). The data reported here shows that there are clear gaps in the knowledge patients have of AMD 300 
risk factors (Sushma, Lamkin, Albanese, Edward, 2010). A lack of information might also explain why four 301 
percent of the participants were not sure what type of AMD they were suffering from. Patients appear to be 302 
actively seeking advice but not all are getting it from sources such as ophthalmologists or optometrists. These 303 
findings are similar to results from the Royal College of Ophthalmologists audit of AMD services in March 2009 304 
(Amoaku & Hubbard, 2009) which found that there was an insufficiency of resources to deliver adequate AMD 305 
Services. Lawrenson and Evan’s survey (2012) of eye professionals (Lawrenson & Evans, 2013) showed that 306 
although over 60% of respondents reported that they frequently provide dietary and supplement advice to 307 
patients with established AMD and those at risk of AMD, the nutritional advice given only consisted of leafy 308 
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green vegetables and oily fish recommendations, and type of supplement recommended did not comply with 309 
current best research evidence, based on the findings of the Age-Related Eye Disease Study (AREDS). Only one 310 
in three optometrists regularly assessed smoking status and advised on smoking cessation (Lawrenson & 311 
Evans, 2013). The results reported in the present study reinforce those of the survey and the Royal College of 312 
Ophthalmologists, and provide further evidence that greater support and information provision for AMD 313 
patients is needed. 314 
 315 
Nutritional supplementation 316 
Over 75% of participants reported taking a nutritional supplement (mainly on a once-per-day basis) – this is a 317 
larger number than other studies into supplement usage have found (Block et al., 2007) (Bartlett & Eperjesi, 318 
2004; Denison et al., 2012). The majority of patients that were taking ocular supplements were not taking an 319 
exact AREDS formulation, and were taking an incorrect dosage or combining it with one or two other brands 320 
with the same formulation (maybe believing that more might be better). This pattern of supplementation 321 
could reflect a lack of information from healthcare professionals, with only a third of patients having discussed 322 
nutritional supplementation with their ophthalmologist, while some participants had not discussed 323 
supplementation with anyone at all. Those participants in our study that reported not taking any supplements 324 
listed the primary reason as not believing they would be effective, and hence were unwilling to spend much 325 
money on an unproven supplement. The high number of nutritional supplements marketed towards people 326 
with AMD makes it difficult for both patients and health professionals to navigate this issue for the prevention 327 
or treatment of the condition (Kent, 2007). There are currently no clear supplement guidelines for health 328 
professionals to use; The College of Optometrists advises that patients should eat a healthy diet and to stop 329 
smoking, adding that there “is no definitive scientific evidence of the effectiveness of nutritional 330 
supplements”, but patients should speak to their optometrist for supplement advice (The College of 331 
Optometrists, 2011). Some institutions might have been waiting for the results of AREDS 2, but since the 332 
AREDS 2 results have been released, there is a need for unified guidelines for all health professionals. When 333 
asked how much participants would be willing to pay for an effective nutritional supplement, only one quarter 334 
responded that they would pay more than £11 per month, and there was a significant correlation between 335 
those who did not take supplements and those that were not willing to spend any money on supplements.  336 
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In conclusion 337 
The development of this survey has created a new measure that can be used again. The study has identified 338 
that AMD patients have a definite lack of information and understanding of the link between AMD and 339 
nutrition, and this needs to be corrected. The results of this study will inform the design of more effective 340 
education and dissemination methods, and help to outline guidelines for health professionals. 341 
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Appendix 1. Survey Questions.  494 
 495 
Questions Options 
How old are you?   
Would you describe yourself as… Male 
  Female 
Do you live… Alone 
  With partner 
  With family 
  With friends 
  Other (please specify) 
Do you live… In own residence 
  In family/ friend's residence 
  In sheltered accommodation 
  In nursing home 
  Other (please specify) 
What is, or was your main occupation   
How would you describe your general health today? How would you describe your vision today? Extremely good 
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  Good 
  Satisfactory 
  Poor 
  Extremely poor 
Do you have the eye condition age-related macular degeneration Yes 
  No  
  Have not heard of this 
condition 
If Yes, how many years have you had it in total?   
What type of age-related macular degeneration do you have?   
Are you on any visually impaired register? Sight impaired (partially 
sighted) 
  Severely sight impaired 
(blind) 
  Neither 
Who MOSTLY prepares your food? You 
  Partner 
  Family member 
  Care giver 
  Other (please specify) 
Who MOSTLY cooks your food? You 
  Partner 
  Family member 
  Care giver 
  Do not eat cooked food 
  Other (please specify) 
What prevents you from preparing food (select all that apply) Visual impairment 
  Physical impairment 
  Nothing 
  Other (please specify) 
Are you able to cook a hot meal on your own? Yes 
  No 
What prevents you from cooking food (select all that apply) Visual impairment 
  Physical impairment 
  Nothing 
  Other (please specify) 
Who MOSTLY does your food shopping? You 
  Friend 
  Family member 
  Care giver 
  Other (please specify) 
Where do you get your food from? (select all that apply) Supermarket 
  Local grocers/ corner shop 
  Internet 
  Meals on wheels 
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  Market 
  Grow own food 
  Other (please specify) 
What is the most important factor that dictates what you eat? Cost 
  Preference 
  Habit 
  Ability to cook or prepare it 
  Ability to acquire it 
  How it affects your health 
  Other (please specify) 
Would you like to change your diet in any way? Yes 
  No 
What prevents you from changing your diet? Visual impairment 
  Physical impairment 
  Nothing 
  Other (please specify) 
  Do not want to change diet 
Please could you describe what you ate yesterday (Breakfast, Lunch, Dinner, Snacks - your interviewer 
will describe portions). 
  
Were the vegetables eaten yesterday (if any)… Mostly cooked 
  Mostly raw 
  No vegetables eaten 
yesterday 
Please state how strongly you agree or disagree with the following statement:  Strongly agree 
There are specific foods that can affect your health. Agree 
  Neither 
  Disagree 
  Strongly disagree 
Please state how strongly you agree or disagree with the following statement: Strongly agree 
 There are specific foods that can affect your EYE health. Agree 
  Neither 
  Disagree 
  Strongly disagree 
Do you think any of the following foods are beneficial for eye health… and why Carrots 
  Ice-cream 
  Spinach 
  Cabbage 
  Kale 
  Bilberries 
  Cheese 
  Peppers 
  Mango 
Which, if any, of the following vegetables did you eat last week? (select all that apply) Carrots 
  Peas 
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  Spinach 
  Cabbage 
  Broccoli 
  Kale 
  None of the above 
Have you ever discussed taking a nutritional supplement with a health specialist or advisor? Yes 
  No 
If yes, who? Ophthalmologist 
  GP 
  Optician 
  Specialist doctor 
  Nurse 
  Herbalist 
  Pharmacist 
  Dietician 
  Helpline worker 
  Other (please specify) 
Do you Currently take any nutritional supplements? Yes 
  No 
If yes, what supplements do you take?   
How often do you take the supplements listed above? More than twice per day 
  Twice per day 
  Once per day 
  Once per week 
  Other (please specify) 
If you answered No, Can you give a reason for not taking a nutritional supplement Too expensive 
  Not sure if effective 
  Fear/ experience of side-
effects 
  worry about interaction with 
other drugs 
  Too much trouble 
  Other (please specify) 
How much money would you be willing to spend on a monthly basis on a nutritional supplement which 
promised good results? 
No money 
  £1-5 
  £6-10 
  £11-15 
  £16-20 
  £20+ 
Please state how strongly you agree or disagree with the following statement: Strongly agree 
 Age-related macular degeneration patients are given enough information on how nutrition affects 
their eye health. 
Agree 
  Neither 
  Disagree 
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  Strongly disagree 
Where have you received information on age-related macular degeneration from? (select all that apply) Opthalmologist 
  Optician 
  Internet 
  Newspapers 
  TV 
  Organisations such as the 
Macular Society 
  Other (please specify) 
Do you believe that age-related macular degeneration can be prevented by lifestyle choices such as 
nutrition? 
Strongly agree 
  Agree 
  Neither 
  Disagree 
  Strongly disagree 
Which changes to the way that you live do you think could affect age-related macular generation?   
 496 
 497 
